Earnings miss despite stock surge. CE reported Q4 2025 GAAP EPS of $0.67, missing the consensus estimate of $0.91 by 26.3%. The chemicals manufacturer posted net income of $74 million on revenue of $2.20 billion. Despite the earnings shortfall, shares jumped 14.7% to $59.60, suggesting investors focused on factors beyond the bottom-line miss.
Profitability metrics show pressure. Gross profit reached $423 million on cost of revenue of $1.78 billion, yielding a gross margin of 19.2%. Operating income totaled $128 million, translating to an operating margin of 5.8%. EBITDA came in at $391 million. The company generated operating cash flow of $252 million and free cash flow of $168 million after capital expenditures of $84 million. The balance sheet shows total debt of $12.61 billion against cash of $1.26 billion and total assets of $21.70 billion.
Guidance signals modest outlook. Management issued revenue guidance of $36 million to $37 million for the coming period, a figure that appears unusually low relative to the $2.20 billion quarterly run rate and warrants clarification on the earnings call. Analyst sentiment remains mixed, with 9 Buy ratings, 8 Hold ratings, and no Sell ratings among the 17 analysts covering the stock.
This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.